Literature DB >> 28619955

Pulmonary artery to aorta ratio and risk of all-cause mortality in the general population: the Rotterdam Study.

Natalie Terzikhan1,2, Daniel Bos2,3,4, Lies Lahousse1,2, Lennard Wolff3, Katia M C Verhamme5, Maarten J G Leening2,4,6, Janine F Felix2, Henning Gall7, Hossein A Ghofrani7, Oscar H Franco2, M Arfan Ikram2,3, Bruno H Stricker8,9, Aad van der Lugt3, Guy Brusselle1,2,10.   

Abstract

A pulmonary artery to aorta ratio (PA:A) >1 is a proxy of pulmonary hypertension. It is not known whether this measure carries prognostic information in the general population and in individuals with chronic obstructive pulmonary disease (COPD).Between 2003 and 2006, 2197 participants from the population-based Rotterdam Study (mean±sd age 69.7±6.7 years; 51.3% female), underwent cardiac computed tomography (CT) scanning with PA:A quantification, defined as the ratio between the diameters of the pulmonary artery and the aorta. COPD was diagnosed based on spirometry or clinical presentation and obstructive lung function measured by a treating physician. Cox regression was used to investigate the risk of mortality.We observed no association between 1-sd increase of PA:A and mortality in the general population. Larger PA:A was associated with an increased risk of mortality in individuals with COPD, particularly in moderate-to-severe COPD (hazard ratio 1.36, 95% CI 1.03-1.79). We demonstrated that the risk of mortality in COPD was driven by severe COPD, and that this risk increased with decreasing diffusing capacity.Larger PA:A is not associated with mortality in an older general population, but is an independent determinant of mortality in moderate-to-severe COPD. Measuring PA:A in CT scans obtained for other indications may yield important prognostic information in individuals with COPD.
Copyright ©ERS 2017.

Entities:  

Mesh:

Year:  2017        PMID: 28619955     DOI: 10.1183/13993003.02168-2016

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  14 in total

1.  Machine Learning and Prediction of All-Cause Mortality in COPD.

Authors:  Matthew Moll; Dandi Qiao; Elizabeth A Regan; Gary M Hunninghake; Barry J Make; Ruth Tal-Singer; Michael J McGeachie; Peter J Castaldi; Raul San Jose Estepar; George R Washko; James M Wells; David LaFon; Matthew Strand; Russell P Bowler; MeiLan K Han; Jorgen Vestbo; Bartolome Celli; Peter Calverley; James Crapo; Edwin K Silverman; Brian D Hobbs; Michael H Cho
Journal:  Chest       Date:  2020-04-27       Impact factor: 9.410

2.  In Rotterdam, size really does matter: implications of pulmonary artery enlargement on mortality.

Authors:  Aline N Zouk; J Michael Wells
Journal:  Eur Respir J       Date:  2017-06-15       Impact factor: 16.671

3.  Pulmonary artery enlargement and mortality risk in moderate to severe COPD: results from COPDGene.

Authors:  David C LaFon; Surya P Bhatt; Wassim W Labaki; Farbod N Rahaghi; Matthew Moll; Russ P Bowler; Elizabeth A Regan; Barry J Make; James D Crapo; Raul San Jose Estepar; Alejandro A Diaz; Edwin K Silverman; MeiLan K Han; Brian Hobbs; Michael H Cho; George R Washko; Mark T Dransfield; J Michael Wells
Journal:  Eur Respir J       Date:  2020-02-12       Impact factor: 16.671

4.  Clinical and prognostic relationships of pulmonary artery to aorta diameter ratio in patients with heart failure: a cardiac magnetic resonance imaging study.

Authors:  Pierpaolo Pellicori; Alessia Urbinati; Jufen Zhang; Anil C Joseph; Pierluigi Costanzo; Elena Lukaschuk; Alessandro Capucci; John G F Cleland; Andrew L Clark
Journal:  Clin Cardiol       Date:  2018-01-23       Impact factor: 2.882

5.  Prognostic Significance of Pulmonary Artery to Aorta Ratio and Other CT Markers in Pulmonary Fibrosis With and Without Emphysema.

Authors:  F Zeba; W Yanning; J Melek; F Duan; M K Atalay; M Jankowich; S Rounds
Journal:  Lung       Date:  2021-11-06       Impact factor: 2.584

6.  Assessment of fully automatic segmentation of pulmonary artery and aorta on noncontrast CT with optimal surface graph cuts.

Authors:  Zahra Sedghi Gamechi; Andres M Arias-Lorza; Zaigham Saghir; Daniel Bos; Marleen de Bruijne
Journal:  Med Phys       Date:  2021-10-29       Impact factor: 4.506

7.  Automated 3D segmentation and diameter measurement of the thoracic aorta on non-contrast enhanced CT.

Authors:  Zahra Sedghi Gamechi; Lidia R Bons; Marco Giordano; Daniel Bos; Ricardo P J Budde; Klaus F Kofoed; Jesper Holst Pedersen; Jolien W Roos-Hesselink; Marleen de Bruijne
Journal:  Eur Radiol       Date:  2019-01-23       Impact factor: 5.315

8.  Pulmonary arterial enlargement predicts long-term survival in COPD patients.

Authors:  Juan P de-Torres; Ana Ezponda; Ana B Alcaide; Arantza Campo; Juan Berto; Jessica Gonzalez; Javier J Zulueta; Ciro Casanova; Luisa Elena Rodriguez-Delgado; Bartolome R Celli; Gorka Bastarrika
Journal:  PLoS One       Date:  2018-04-25       Impact factor: 3.240

Review 9.  Leveraging the coronary calcium scan beyond the coronary calcium score.

Authors:  Daniel Bos; Maarten J G Leening
Journal:  Eur Radiol       Date:  2018-01-30       Impact factor: 5.315

Review 10.  Assessing pulmonary hypertension in COPD. Is there a role for computed tomography?

Authors:  Florence Coste; Ilyes Benlala; François Laurent; Patrick Berger; Gaël Dournes; Pierre-Olivier Girodet
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-09-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.